Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa

Journal of the International AIDS Society

Volumn 18, Issue 1, 2015, Pages

  Myer, Landon ^a   Phillips, Tamsin K ^a   Hsiao, Nei Yuan ^a,b   Zerbe, Allison ^c   Petro, Gregory ^a   Bekker, Linda Gail ^a   McIntyre, James A ^a,d   Abrams, Elaine J ^c,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c National Health Laboratory Services ^*  (United States)

^d ANOVA HEALTH INSTITUTE   (South Africa)

^e Department of Obstetrics and Gynaecology University of Cape Town ^*  (United States)

Author keywords

Antiretroviral therapy; Pregnancy; Prevention of mother to child transmission; South Africa; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS TENOFOVIR DISOPROXIL; NEVIRAPINE; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOTHER TO CHILD TRANSMISSION; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SOUTH AFRICA; VIREMIA; VIRUS LOAD; VIRUS TRANSMISSION; YOUNG ADULT; HIV INFECTIONS; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVENTION AND CONTROL; VERTICAL TRANSMISSION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; SOUTH AFRICA; VIREMIA;

EID: 84937116811     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.18.1.20045     Document Type: Article

References (14)

1. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Curr Opin HIV AIDS. 2013;8:474-89.
2. Roberts T, Bygrave H, Fajardo E, Ford N. Challenges and opportunities for the implementation of virological testing in resource-limited settings. J Int AIDS Soc. 2012;15(2):17324.
3. Kesho Bora Study Group. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1: a randomised controlled trial. Lancet Infect Dis. 2011;11(3):171-80.
4. Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, Moffat C, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362(24):2282-94.
5. Myer L, Phillips TK, Manuelli V, Bekker LG, McIntyre J, Abrams EJ. Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2015;69(2):e57-e65.
6. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341(6):394-402.
7. Kranzer K, Lawn SD, Johnson LF, Bekker LG, Wood R. Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention. J Acquir Immune Defic Syndr. 2013;63(4):498-505.
8. Jain V, Liegler T, Kabami J, Chamie G, Clark TD, Black D, et al. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. Clin Infect Dis. 2013;56(4):598-605.
9. Heffron R, Donnell D, Kiarie J, Rees H, Ngure K, Mugo N, et al. A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women. J Acquir Immune Defic Syndr. 2014;65(2):231-6.
10. Carter RJ, Dugan K, El-Sadr WM, Myer L, Otieno J, Pungpapong N, et al. CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr. 2010;55(3):404-10.
11. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO; 2013.
12. Johnson L. Access to antiretroviral treatment in South Africa, 2004-2011. Southern Afr J HIV Med. 2012;13(1):22-7.
13. World Health Organization. March 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: WHO; 2014.
14. Izzo I, Forleo MA, Casari S, Quiros-Roldan E, Magoni M, Carosi G, et al. Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study. BMC Public Health. 2011;11:124.